Cursus Bio Inc.

category

  • - MEDICAL BEAUTY

Company Instruction

Cursus Bio, established in 2021, is a biotech company specializing in drug delivery systems and metabolic disease therapeutics. Our mission is to translate advanced biological research into clinically applicable solutions.
Our core technology, MicroLock™, is a patented self-interlocking microneedle platform designed for precise transdermal drug delivery. Its diamond-shaped structure enhances skin anchoring while minimizing discomfort. A proprietary low-temperature process helps preserve the bioactivity of sensitive therapeutics, including peptides and nucleic acids.
We are also developing an adipocyte-targeted gene therapy approach. By modulating FABP4/5 expression, it aims to promote fat browning and improve metabolic outcomes.
Supported by publications in internationally recognized scientific journals and CGMP-grade manufacturing capabilities, Cursus Bio is committed to advancing next-generation healthcare solutions.

Product : 1